Ram Gopalakrishnan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ram Gopalakrishnan has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Nandini Sethuraman
Department of Microbiology, Apollo Hospitals, Chennai, Tamil Nadu, India
5 shared publications - Senthur Nambi
Department of Infectious Diseases, Apollo Hospitals, Chennai, Tamil Nadu, 600006, India
3 shared publications - Chitra Chandran
Apollo Hosp, Dept Mol Diagnost, Chennai, Tamil Nadu, India
2 shared publications - Venkatasubramanian Ramasubramanian
Department of Infectious Diseases, Apollo Hospitals, Chennai, India
2 shared publications - Venkatasubramanian Ramasubramanian
Department of Infectious Diseases, Capstone Multispeciality Clinic & Apollo Hospital, Chennai 600017, India
2 shared publications - Yamunadevi Ramanathan
Senior Consultant Infection Prevention and Control, Apollo Hospital, Chennai, India
2 shared publications
Latest Publications
- 17 September 2025
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 58, 100974
Management of infections caused by Extended-spectrum beta-lactamase-producing Enterobacterales in Indian patients
- 17 September 2025
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 58, 100974
Management of infections caused by Extended-spectrum beta-lactamase-producing Enterobacterales in Indian patients
- Open Access
- 1 July 2024
- Published by Medknow in Journal of Clinical Infectious Diseases Society
- Vol. 2 (3) , 151-153
A Challenging Case with HIV/AIDS and a Multisystem Disease
We report a case of 47 year old male from a rural area in Bihar with fever of 1 month duration, dry cough, weight loss and loss of appetite. He also had papular rash on the face. His laboratory investigations were notable for bicytopenia and elevated creatinine levels. He also had transaminase elevation, albumin globulin reversal and markedly elevated alkaline phosphatase, GGT levels. Ferritin and LDH were markedly elevated. Chest X ray and USG Abdomen revealed normal study. Bone marrow biopsy revealed the diagnosis. Eventually an unusual co infection was identified.
- 1 July 2024
- Published by Medknow in Journal of Clinical Infectious Diseases Society
- Vol. 2 (3) , 151-153
Open AccessA Challenging Case with HIV/AIDS and a Multisystem Disease
We report a case of 47 year old male from a rural area in Bihar with fever of 1 month duration, dry cough, weight loss and loss of appetite. He also had papular rash on the face. His laboratory investigations were notable for bicytopenia and elevated creatinine levels. He also had transaminase elevation, albumin globulin reversal and markedly elevated alkaline phosphatase, GGT levels. Ferritin and LDH were markedly elevated. Chest X ray and USG Abdomen revealed normal study. Bone marrow biopsy revealed the diagnosis. Eventually an unusual co infection was identified.
- 30 May 2024
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 50, 100620
An elderly male with septic arthritis and bacteremia
- 30 May 2024
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 50, 100620
An elderly male with septic arthritis and bacteremia
- Open Access
- 30 April 2024
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 28 (5) , 461-466
Clinical Utility of Blood Culture Identification 2 Panel in Flagged Blood Culture Samples from the Intensive Care Unit of a Tertiary Care Hospital
Background: The availability of rapid diagnostic platforms for positive blood cultures has accelerated the speed at which the clinical microbiology laboratory can identify the causative organism and facilitate early appropriate antimicrobial therapy. There is a paucity of data regarding the clinical utility of the blood culture identification 2 (BCID2) panel test and its correlation with phenotypic drug susceptibility testing (DST) in flagged blood culture bottles from intensive care units (ICUs) in countries such as India, which have high rates of multidrug-resistant gramnegative bacteria (MDR-GNB). Materials and methods: We conducted a retrospective observational study in a tertiary care ICU on 200 patients above 18 years of age in whom a BCID2 test was ordered when blood cultures flagged positive. Results: We found 99% concordance between BCID2 and cultures in the identification of bacteria and yeasts and 96.5% concordance between phenotypic and genotypic DST. Furthermore, BCID2 was available about 1.5 days earlier than conventional ID and DST and played a key role in tailoring antimicrobials in 82.5% of the patients. Polymyxin-based therapy was discontinued earlier after an empiric dose in 138 patients (69%) based on BCID2 reports. Conclusion: In critically ill patients with monomicrobial bacteremia, BCID2 rapidly identifies bacteria and antimicrobial resistance (AMR) genes and is significantly faster than conventional culture and sensitivity testing. Antibiotics were escalated in more than a third of patients and de-escalated in almost a fifth on the same day. We recommend that all ICUs routinely incorporate the test in their antibiotic decision-making process and in antimicrobial stewardship.
- 30 April 2024
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 28 (5) , 461-466
Open AccessClinical Utility of Blood Culture Identification 2 Panel in Flagged Blood Culture Samples from the Intensive Care Unit of a Tertiary Care Hospital
Background: The availability of rapid diagnostic platforms for positive blood cultures has accelerated the speed at which the clinical microbiology laboratory can identify the causative organism and facilitate early appropriate antimicrobial therapy. There is a paucity of data regarding the clinical utility of the blood culture identification 2 (BCID2) panel test and its correlation with phenotypic drug susceptibility testing (DST) in flagged blood culture bottles from intensive care units (ICUs) in countries such as India, which have high rates of multidrug-resistant gramnegative bacteria (MDR-GNB). Materials and methods: We conducted a retrospective observational study in a tertiary care ICU on 200 patients above 18 years of age in whom a BCID2 test was ordered when blood cultures flagged positive. Results: We found 99% concordance between BCID2 and cultures in the identification of bacteria and yeasts and 96.5% concordance between phenotypic and genotypic DST. Furthermore, BCID2 was available about 1.5 days earlier than conventional ID and DST and played a key role in tailoring antimicrobials in 82.5% of the patients. Polymyxin-based therapy was discontinued earlier after an empiric dose in 138 patients (69%) based on BCID2 reports. Conclusion: In critically ill patients with monomicrobial bacteremia, BCID2 rapidly identifies bacteria and antimicrobial resistance (AMR) genes and is significantly faster than conventional culture and sensitivity testing. Antibiotics were escalated in more than a third of patients and de-escalated in almost a fifth on the same day. We recommend that all ICUs routinely incorporate the test in their antibiotic decision-making process and in antimicrobial stewardship.
- 19 February 2024
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 48, 100539
Epidemiology and outcomes of infections during extracorporeal membrane oxygenation in adult patients with COVID-19 ARDS- A single center study
- 19 February 2024
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 48, 100539
Epidemiology and outcomes of infections during extracorporeal membrane oxygenation in adult patients with COVID-19 ARDS- A single center study
- Open Access
- 31 August 2023
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 27 (9) , 655-662
Xpert Carba-R Assay on Flagged Blood Culture Samples: Clinical Utility in Intensive Care Unit Patients with Bacteremia Caused by Enterobacteriaceae
Rapid molecular diagnostics to predict carbapenem resistance well before the availability of routine drug sensitivity testing (DST) can serve as an antimicrobial stewardship tool in the context of high rates of Carbapenem-resistant Enterobacteriaceae (CRE). A retrospective observational study of patients more than 18 years of age on whom Xpert Carba-R (FDA approved for rectal swab specimen) was done on gram-negative bacteria (GNB) flagged blood culture samples, in an Indian intensive care unit between January 2015 and November 2018. We analyzed the performance of Xpert Carba-R in comparison with routine DST. A total of 164 GNBs were isolated from 160 patients. Klebsiella pneumoniae and Escherichia coli were the predominant isolates. Carba-R was positive in 35.36% of samples and 45.34% were carbapenem-resistant (CR) on routine DST. The distribution of the CR gene was: Oxacillinase (OXA) (50%), NDM (32.7%) followed by OXA and NDM co-expression (15.51%). The sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, positive predictive value, and negative predictive value of Carba-R were 90.74, 93.15, 13.25, 0.10, 83.58 and 96.31% for Enterobacteriaceae. The median time to obtain the Carba-R report was 30 hours 34 minutes vs 74 hours and 20 minutes for routine DST. Based on the Carba-R report, 9.72% of patients had escalation and 27.08% had de-escalation of antibiotics. Xpert Carba-R serves as a rapid diagnostic tool for predicting carbapenem resistance in intensive care unit patients with bacteremia caused by Enterobacteriaceae. Rajendran S, Gopalakrishnan R, Tarigopula A, Kumar DS, Nambi PS, Sethuraman N, et al. Xpert Carba-R Assay on Flagged Blood Culture Samples: Clinical Utility in Intensive Care Unit Patients with Bacteremia Caused by Enterobacteriaceae. Indian J Crit Care Med 2023;27(9):655–662.
- 31 August 2023
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 27 (9) , 655-662
Open AccessXpert Carba-R Assay on Flagged Blood Culture Samples: Clinical Utility in Intensive Care Unit Patients with Bacteremia Caused by Enterobacteriaceae
Rapid molecular diagnostics to predict carbapenem resistance well before the availability of routine drug sensitivity testing (DST) can serve as an antimicrobial stewardship tool in the context of high rates of Carbapenem-resistant Enterobacteriaceae (CRE). A retrospective observational study of patients more than 18 years of age on whom Xpert Carba-R (FDA approved for rectal swab specimen) was done on gram-negative bacteria (GNB) flagged blood culture samples, in an Indian intensive care unit between January 2015 and November 2018. We analyzed the performance of Xpert Carba-R in comparison with routine DST. A total of 164 GNBs were isolated from 160 patients. Klebsiella pneumoniae and Escherichia coli were the predominant isolates. Carba-R was positive in 35.36% of samples and 45.34% were carbapenem-resistant (CR) on routine DST. The distribution of the CR gene was: Oxacillinase (OXA) (50%), NDM (32.7%) followed by OXA and NDM co-expression (15.51%). The sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, positive predictive value, and negative predictive value of Carba-R were 90.74, 93.15, 13.25, 0.10, 83.58 and 96.31% for Enterobacteriaceae. The median time to obtain the Carba-R report was 30 hours 34 minutes vs 74 hours and 20 minutes for routine DST. Based on the Carba-R report, 9.72% of patients had escalation and 27.08% had de-escalation of antibiotics. Xpert Carba-R serves as a rapid diagnostic tool for predicting carbapenem resistance in intensive care unit patients with bacteremia caused by Enterobacteriaceae. Rajendran S, Gopalakrishnan R, Tarigopula A, Kumar DS, Nambi PS, Sethuraman N, et al. Xpert Carba-R Assay on Flagged Blood Culture Samples: Clinical Utility in Intensive Care Unit Patients with Bacteremia Caused by Enterobacteriaceae. Indian J Crit Care Med 2023;27(9):655–662.
- Open Access
- 1 March 2021
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 25 (3) , 258-259
Melioidosis-Commonly Missed, Yet Not Uncommon and Eminently Treatable
It would be a wise practice for intensivists to always consider the diagnosis of melioidosis in all patients with undifferentiated septic shock, focal abscesses, and severe community-acquired or necrotizing pneumonia. Culturing adequate volumes of blood before giving antibiotics and obtaining cultures from the clinically involved sites facilitates the diagnosis. Empiric therapy should always include a carbapenem till the diagnosis is excluded or confirmed and appropriate management usually leads to an extremely satisfactory outcome.
- 1 March 2021
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 25 (3) , 258-259
Open AccessMelioidosis-Commonly Missed, Yet Not Uncommon and Eminently Treatable
It would be a wise practice for intensivists to always consider the diagnosis of melioidosis in all patients with undifferentiated septic shock, focal abscesses, and severe community-acquired or necrotizing pneumonia. Culturing adequate volumes of blood before giving antibiotics and obtaining cultures from the clinically involved sites facilitates the diagnosis. Empiric therapy should always include a carbapenem till the diagnosis is excluded or confirmed and appropriate management usually leads to an extremely satisfactory outcome.
- 1 November 2020
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 14 (6) , 2245-2249
D-dimer level is a useful predictor for mortality in patients with COVID-19: Analysis of 483 cases
- 1 November 2020
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 14 (6) , 2245-2249
D-dimer level is a useful predictor for mortality in patients with COVID-19: Analysis of 483 cases
- 14 May 2020
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 37 (S2) , 267-274
Sepsis and ECMO
Sepsis is being recognized as an important complication of extracorporeal membrane oxygenation (ECMO) and its presence is a poor prognostic marker and increases the overall mortality. The survival rate differs in the various types of cannulation techniques. Adult patients with prolonged duration of ECMO constitute the major risk population. Ventilator-associated pneumonia and bloodstream infections form the main sources of sepsis in these patients. It is important to know the most common etiological agents for sepsis in ECMO, which varies partly with the local epidemiology of the hospitals. A high index of suspicion, drawing adequate volumes for blood culture and early and timely administration of appropriate empirical antimicrobials can substantially decrease the morbidity and mortality in this high-risk population. The dosing of antimicrobials is influenced by the pharmacological variations on ECMO machine and is an important consideration. Infection control practices are of paramount importance and need to be followed meticulously to prevent sepsis in ECMO.
- 14 May 2020
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 37 (S2) , 267-274
Sepsis and ECMO
Sepsis is being recognized as an important complication of extracorporeal membrane oxygenation (ECMO) and its presence is a poor prognostic marker and increases the overall mortality. The survival rate differs in the various types of cannulation techniques. Adult patients with prolonged duration of ECMO constitute the major risk population. Ventilator-associated pneumonia and bloodstream infections form the main sources of sepsis in these patients. It is important to know the most common etiological agents for sepsis in ECMO, which varies partly with the local epidemiology of the hospitals. A high index of suspicion, drawing adequate volumes for blood culture and early and timely administration of appropriate empirical antimicrobials can substantially decrease the morbidity and mortality in this high-risk population. The dosing of antimicrobials is influenced by the pharmacological variations on ECMO machine and is an important consideration. Infection control practices are of paramount importance and need to be followed meticulously to prevent sepsis in ECMO.